Somite Therapeutics, Inc. — Form D
Somite Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-26. The offering totals $47.5M, of which $47.5M was reported sold. Industry: Other.
Offering
- Filed: 2025-11-26
- Form: D
- Accession: 0001231919-25-000557
- Industry: Other
- Exemptions: 06b
- Total offering: $47.5M
- Amount sold: $47.5M
- Investors: 30
- Date of first sale: 2025-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-565224
Issuer
- Name: Somite Therapeutics, Inc.
- CIK: 0002075078
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 40 GUEST STREET, BOSTON, MA, 02135
- Phone: 512-270-9113
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Micah Breakstone | Director | BOSTON, MA |
| Chad Cowan | Director | BOSTON, MA |
| Steven Holtzman | Director | BOSTON, MA |
| Micah Breakstone | Executive Officer | BOSTON, MA |
| Micah Breakstone | Promoter | BOSTON, MA |
More